Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remission Through Early Monitored Insulin Therapy - Duration Month

NCT03670641 is registered in ClinicalTrials.gov with Sandra Sobel as lead sponsor.

NCT NCT03670641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03670641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remission Through Early Monitored Insulin Therapy - Duration Month
Lead sponsor
Sandra Sobel
Phase
Phase 4
Overall status
Completed
Start date
March 26, 2019
Completion date
July 31, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus